Toronto Dominion Bank Acquires 4,455 Shares of Humana Inc. (NYSE:HUM)

Toronto Dominion Bank raised its holdings in Humana Inc. (NYSE:HUM - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,447 shares of the insurance provider's stock after acquiring an additional 4,455 shares during the period. Toronto Dominion Bank owned about 0.05% of Humana worth $16,351,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GF Fund Management CO. LTD. acquired a new stake in shares of Humana during the fourth quarter valued at about $763,000. Sunbelt Securities Inc. boosted its stake in shares of Humana by 49.3% during the fourth quarter. Sunbelt Securities Inc. now owns 609 shares of the insurance provider's stock valued at $155,000 after purchasing an additional 201 shares in the last quarter. GTS Securities LLC boosted its stake in shares of Humana by 104.5% during the fourth quarter. GTS Securities LLC now owns 1,256 shares of the insurance provider's stock valued at $319,000 after purchasing an additional 29,057 shares in the last quarter. Vise Technologies Inc. boosted its stake in shares of Humana by 8.0% during the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock valued at $221,000 after purchasing an additional 65 shares in the last quarter. Finally, Focus Partners Advisor Solutions LLC acquired a new stake in shares of Humana during the fourth quarter valued at about $387,000. Institutional investors own 92.38% of the company's stock.

Humana Stock Up 1.2%

Humana stock traded up $2.83 during trading on Friday, hitting $232.91. 2,524,287 shares of the company were exchanged, compared to its average volume of 1,780,927. The business's 50 day moving average is $257.11 and its 200 day moving average is $266.53. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a market capitalization of $28.11 billion, a P/E ratio of 23.41, a PEG ratio of 2.05 and a beta of 0.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same quarter in the prior year, the company posted $7.23 earnings per share. Humana's revenue was up 8.4% compared to the same quarter last year. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.52%. Humana's dividend payout ratio is currently 25.04%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on HUM shares. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. JPMorgan Chase & Co. cut their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Raymond James raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Robert W. Baird lifted their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Finally, Mizuho lifted their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Sixteen analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $286.81.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.